DFIB Cardiac Science (MM)

Merger Expected to Close September 1, 2005 BOTHELL, Wash. and IRVINE, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Quinton Cardiology Systems, Inc. (NASDAQ:QUIN), a global leader in advanced cardiology products, and Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public-access defibrillators, announced that the stockholders of both companies have approved the merger of Quinton Cardiology Systems and Cardiac Science at their respective special stockholder meetings held earlier today. The transaction was approved by the holders of a majority of the shares of each company outstanding as of the record dates for the special meetings. Approximately 96 percent of the shares of Cardiac Science common stock cast at the Cardiac Science special meeting and approximately 97 percent of the shares of Quinton common stock cast at the Quinton special meeting voted in favor of the merger proposal. The parties expect to close the merger on September 1, 2005. This press release includes forward-looking statements relating to the timing and certainty of the consummation of the transaction. Quinton and Cardiac Science have based these forward-looking statements on the current expectations and beliefs. While Quinton and Cardiac Science believe these expectations are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond each company's respective control. These risks include the risk that the transaction may not be completed on September 1, 2005 as expected. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. Neither Cardiac Science nor Quinton undertakes any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments. For Cardiac Science Investors Matt Clawson (Investors) Len Hall (Media) Allen & Caron Inc (949) 474-4300 Cardiac Science Roderick de Greef EVP and CFO (949) 797-3800 Quinton Cardiology Systems Mike Matysik Sr. Vice President and CFO (425) 402-2009 DATASOURCE: Quinton Cardiology Systems, Inc.; Cardiac Science, Inc. CONTACT: investors, Matt Clawson, or media, Len Hall, both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Roderick de Greef, EVP and CFO of Cardiac Science, Inc., +1-949-797-3800; or Mike Matysik, Sr. Vice President and CFO of Quinton Cardiology Systems, +1-425-402-2009

Copyright